MEN1 and primary hyperparathyroidism: Honda et al (12) reported a case with an unusual combination of primary hyperparathyroidism, primary aldosteronism and breast cancer, in a patient with a germline MEN1 gene mutation, which is regarded as a benign polymorphism and loss of heterozygosity (LOH) of the MEN1 locus in the DNA from breast cancer tissue.